HCV Drug Therapy and the DNA Base Excision Repair System
The Influence of New Anti-HCV Therapy on the DNA Base Excision Repair System of Peripheral Blood Mononuclear Cells
The Prodrug Opportunity: Making Good Drugs Better
Elegance in Chemistry, Product Development, and Marketability
- INFOGRAPHIC: Spotlight on How a Discovery Program Was Born
Looking at the CAR-T Landscape as First Approval Nears
Sounds of Science Podcast
Sagar Anisingaraju is the Chief Strategy Officer of Saama Technologies. He is passionate in helping customers derive business outcomes and a differentiating analytics advantage with their data assets. He was the winner of the ‘Chief Strategy Officer of the Year’ award from Innovation Enterprise in 2013. His recent contributions include architecting advanced analytics engine and solutions for a variety of industries. This analytics engine is used by Life Sciences companies to capture and manage data at all stages of the value chain: from Bench to Bedside to derive insights and implement proactive programs. He is a contributor to publications on use of Big Data by pharma companies and providers.
Prior to joining Saama, Sagar founded and ran InfoSTEP Inc. for 11 years as CEO till its acquisition by Saama.
More GEN Content From This Contributor
- GEN Exclusives: Optimizing Clinical Trials